v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
REAL PROPERTY RENTAL REVENUE $ 345,159 $ 331,290 $ 987,634 $ 934,360
REAL PROPERTY OPERATING EXPENSES 245,528 288,083 794,142 781,931
REAL PROPERTY OPERATING INCOME 99,631 43,207 193,492 152,429
(LOSS) INCOME FROM EQUITY METHOD INVESTMENT - LAB SERVICES MSO (447,909) 354,500 (669,777) 370,060
OTHER OPERATING EXPENSES:        
Advertising and marketing expenses 144,734 437,750 252,394 1,634,720
Professional fees 303,332 435,144 1,190,125 2,659,895
Compensation and related benefits 343,360 469,959 1,054,164 1,375,637
Other general and administrative expenses 130,257 195,990 644,418 815,068
Total Other Operating Expenses 921,683 1,538,843 3,141,101 6,485,320
LOSS FROM OPERATIONS (1,269,961) (1,141,136) (3,617,386) (5,962,831)
OTHER (EXPENSE) INCOME        
Interest expense - amortization of debt discount and debt issuance costs (278,811) (199,136) (1,115,433) (290,794)
Interest expense - other (257,722) (229,144) (726,776) (527,702)
Interest expense - related party (10,712) (10,712) (31,904) (23,000)
Change in fair value of derivative liability 169,209 87,173 380,758 128,894
Impairment of equity method investment - Epicon (464,406)
Other (expense) income (31,203) 7,880 (67,998) (12,037)
Total Other Expense, net (409,239) (343,939) (1,561,353) (1,189,045)
LOSS BEFORE INCOME TAXES (1,679,200) (1,485,075) (5,178,739) (7,151,876)
INCOME TAXES
NET LOSS (1,679,200) (1,485,075) (5,178,739) (7,151,876)
LESS: NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTEREST
NET LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS $ (1,679,200) $ (1,485,075) $ (5,178,739) $ (7,151,876)
NET LOSS PER COMMON SHARE ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS:        
Net Loss Per Common Share Attributable Common Shareholders Basic (in Dollars per share) $ (1.82) $ (2.06) $ (6.45) $ (10.34)
Net Loss Per Common Share Attributable Common Shareholders diluted (in Dollars per share) $ (1.82) $ (2.06) $ (6.45) $ (10.34)
Weighted Average Common Shares Outstanding Basic (in Shares) 924,431 719,699 802,983 691,496
Weighted Average Common Shares Outstanding diluted (in Shares) 924,431 719,699 802,983 691,496
COMPREHENSIVE LOSS:        
NET LOSS $ (1,679,200) $ (1,485,075) $ (5,178,739) $ (7,151,876)
OTHER COMPREHENSIVE INCOME (LOSS)        
Unrealized foreign currency translation gain (loss) 3,043 (8,685) 2,829 (16,026)
COMPREHENSIVE LOSS (1,676,157) (1,493,760) (5,175,910) (7,167,902)
LESS: COMPREHENSIVE LOSS ATTRIBUTABLE TO NONCONTROLLING INTEREST
COMPREHENSIVE LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS $ (1,676,157) $ (1,493,760) $ (5,175,910) $ (7,167,902)

Source